Breast Cancer

/Tag: Breast Cancer

Does vitamin D enhance the survival rate of breast cancer patients?

2016-09-29T11:52:38+00:00

[et_pb_section admin_label="section"][et_pb_row admin_label="row"][et_pb_column type="4_4"][et_pb_text admin_label="Text" background_layout="light" text_orientation="left" use_border_color="off" border_color="#ffffff" border_style="solid"] There have been several studies into the link between breast cancer survival and the ‘sunshine vitamin’ (vitamin D).  Although it is too early to refer to vitamin D as a new weapon in our armamentarium, the association has created a lot of interest and indeed may lead to important new discoveries in the future. The results of these studies are worth exploring. Published earlier this year in the Anticancer Research Journal is a study by the University of California’s San Diego School of Medicine (led by Prof Cedric Garland), which showed [...]

Does vitamin D enhance the survival rate of breast cancer patients? 2016-09-29T11:52:38+00:00

Breast Cancer Treatment Breakthrough Claimed by 16-Year-Old Boy

2016-08-30T08:38:44+00:00

[et_pb_section admin_label="section"][et_pb_row admin_label="row"][et_pb_column type="4_4"][et_pb_text admin_label="Text" background_layout="light" text_orientation="left" use_border_color="off" border_color="#ffffff" border_style="solid"] Krtin Nithiyanandam is hoping to gain interest from the scientific community to develop the work further A 16-year-old boy claims to have discovered the cure for one of the most dangerous forms of breast cancer. Krtin Nithiyanandam from Epsom, Surrey, believes he has found a way to turn the most deadly form of triple negative breast cancer into one which is responsive to treatment. The teenager, who won the Google Science Fair in 2015 for creating an Alzheimer’s test which can spot early signs of the disease, has been working on the [...]

Breast Cancer Treatment Breakthrough Claimed by 16-Year-Old Boy 2016-08-30T08:38:44+00:00

South Africa Seeks Price Cut for Breast Cancer Drug

2016-05-24T08:11:45+00:00

[et_pb_section admin_label="section"][et_pb_row admin_label="row"][et_pb_column type="4_4"][et_pb_text admin_label="Text" background_layout="light" text_orientation="left" use_border_color="off" border_color="#ffffff" border_style="solid"] Swiss pharmaceutical manufacturer Roche said that talks with the Department of Health to widen access to its breast cancer drug trastuzumab, branded herceptin, were at an “advanced stage”. Roche holds the patent on herceptin, which costs about R500,000 for a year’s course in the private sector. Its high price means many medical schemes do not pay for it, or will pay only for a limited course. It is generally not available for public sector patients. Herceptin is used in conjunction with other therapies for a particularly aggressive form of the disease [...]

South Africa Seeks Price Cut for Breast Cancer Drug 2016-05-24T08:11:45+00:00